Coherus Oncology (CHRS) Operating Leases (2019 - 2026)
Coherus Oncology (CHRS) posted Operating Leases of $459,000 for Q2 2026, down 80.9% from $2.41 million a year earlier and down 51.9% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology's Operating Leases came in at $1.46 million, down 55.7% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of -31.9% (FY2020 to FY2025).
- In prior years, Coherus Oncology's Operating Leases was $3.29 million in FY2024 (-38.3%), $5.33 million in FY2023 (+5.6%), $5.05 million in FY2022 (-30.4%) and $7.25 million in FY2021 (-27.1%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q1 2019.
- On a year-over-year basis, Operating Leases has declined in each of the last seven quarters, with an average decline of 26.3% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q3 2024, with growth of 160.2%; the weakest was Q2 2026, with a decline of 80.9%.
- According to Business Quant data, Operating Leases for the three prior quarters was $954,000 (Q1 2026), $1.46 million (Q4 2025) and $1.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 459,000.00 |
| Mar 31, 2026 | 954,000.00 |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 3.29 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 4.17 Mn |
| Mar 31, 2024 | 4.68 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 2.62 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 5.05 Mn |
| Sep 30, 2022 | 6.12 Mn |
| Jun 30, 2022 | 6.81 Mn |
| Mar 31, 2022 | 6.52 Mn |
| Dec 31, 2021 | 7.25 Mn |
| Sep 30, 2021 | 7.97 Mn |
API Access
Coherus Oncology Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();